Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epithelial Tumor, Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT03686709
What this trial is testing

Y90 Radioembolization Dose Delivery and Radiation Exposure Assessment

Who this might be right for
Hepatocellular CarcinomaRadiation Exposure
University of Tennessee 20
Not applicableLooking for participantsNCT06167109
What this trial is testing

NBI Combined With MRI to Guide CTV Optimization in Eccentric Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma by AJCC V8 Stage
Chongqing University Cancer Hospital 60
Not applicableStudy completedNCT05233098
What this trial is testing

TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.

Who this might be right for
Hepatocellular Carcinoma
Boston Scientific Corporation 6
Testing effectiveness (Phase 2)Study completedNCT02607553
What this trial is testing

Safety and Activity of G-202 in Patients With Clear Cell Renal Cell Carcinoma That Expresses PSMA

Who this might be right for
Clear Cell Renal Cell Carcinoma
GenSpera, Inc. 2
Large-scale testing (Phase 3)UnknownNCT05056337
What this trial is testing

Toripalimab in Combination With Lenvatinib and TACE for Conversion Therapy in Patients With Potentially Resectable HCC

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 220
Not applicableWithdrawnNCT01847495
What this trial is testing

Evaluation of Low-dose Irinotecan and Cyberknife® SBRT to Treat Colorectal Cancer With Limited Liver Metastasis

Who this might be right for
Colorectal Cancer
Wake Forest University Health Sciences
Early research (Phase 1)Study completedNCT01379339
What this trial is testing

Cabazitaxel - PF Induction Chemotherapy

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Krzysztof Misiukiewicz 40
Testing effectiveness (Phase 2)Study completedNCT00001239
What this trial is testing

Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast Cancer

Who this might be right for
Breast CancerBreast Neoplasms
National Cancer Institute (NCI) 100
Not applicableStudy completedNCT01487057
What this trial is testing

Lipid Metabolic Status in Thyroid Carcinoma

Who this might be right for
Thyroid CarcinomaDyslipidemiasRisk Reduction Behavior+1 more
Prof. Dr. I. Chiricuta Institute of Oncology 52
Testing effectiveness (Phase 2)WithdrawnNCT02649530
What this trial is testing

A Phase II Trial Evaluating WNT974 in Patients With Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma, Head And Neck
University of Michigan Rogel Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01725165
What this trial is testing

Surgery and/or Radiation Therapy or Standard Therapy and/or Clinical Observation in Treating Patients With Previously Treated Stage IV Non-small Cell Lung Cancer

Who this might be right for
Recurrent Lung Non-Small Cell CarcinomaStage IV Non-Small Cell Lung Cancer AJCC v7
M.D. Anderson Cancer Center 85
Testing effectiveness (Phase 2)Ended earlyNCT00549328
What this trial is testing

Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 14
Early research (Phase 1)UnknownNCT01456065
What this trial is testing

Safety of Active Immunotherapy in Subjects With Ovarian Cancer

Who this might be right for
Ovarian Epithelial Cancer
Life Research Technologies GmbH 15
Early research (Phase 1)Ended earlyNCT03634267
What this trial is testing

MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer

Who this might be right for
Human Papillomavirus-Related CarcinomaHuman Papillomavirus-Related Cervical CarcinomaStage IB2 Cervical Cancer AJCC v8+14 more
M.D. Anderson Cancer Center 26
Not applicableLooking for participantsNCT02682667
What this trial is testing

Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols

Who this might be right for
Multiple MyelomaLymphoma, Non-HodgkinLeukemia-Lymphoma, Adult T-Cell+2 more
National Cancer Institute (NCI) 500
Testing effectiveness (Phase 2)Looking for participantsNCT06363734
What this trial is testing

Osimertinib Plus Dalpiciclib in Patients With EGFR-mutant, CDK4/6 Pathway Aberrant, Advanced Non-small Cell Lung Cancer Following Acquired Resistance to Third-generation EGFR TKI: a Phase II Trial

Who this might be right for
Non-small Cell Lung CancerEGFR Activating MutationCell Cycle Deregulation+1 more
Tianjin Medical University Cancer Institute and Hospital 32
Not applicableActive Not RecruitingNCT06141564
What this trial is testing

Detect and Expunge Concealed Tumors of the Liver

Who this might be right for
Liver Cancer
Johns Hopkins University 360
Testing effectiveness (Phase 2)WithdrawnNCT00668499
What this trial is testing

VEGF-Antisense Oligonucleotide in Combination With Pemetrexed and Cisplatin for the Treatment of Advanced Malignant Mesothelioma

Who this might be right for
Mesothelioma
University of Southern California
Testing effectiveness (Phase 2)UnknownNCT04524299
What this trial is testing

Study of Radiotherapy Combined With Albumin Bound Paclitaxel and Nedaplatin for Locally Advanced NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 160
Not applicableWithdrawnNCT01300299
What this trial is testing

STEREOtactic Radiation and Chemotherapy in Lung Cancer (STEREO)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
University of Louisville
Next Page